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Aim: To describe a new research tool, designed to reflect routine clinical practice and relying on 
population-based health care databases to detect clinical events in randomized clinical trials.
Background: Randomized clinical trials often focus on short-term efficacy and safety in a 
controlled environment. Trial follow-up may be linked with study-related investigations and 
differ from routine clinical practice. Because treatment and control in randomized trials differ 
from daily practice, trial results may have reduced general applicability and may be of limited 
value in clinical decision-making. Further, it is economically very costly to conduct random-
ized clinical trials.
Methods and results: Population-based health care databases collect data continuously and 
prospectively, and make it possible to monitor lifelong outcomes of cardiac interventions in 
large numbers of patients. This strengthens external validity by eliminating the effects of study-
related monitoring or diagnostic tests. Further, follow-up data can be obtained at low expense. 
Importantly, data sources encompassing a complete population are likely to reflect clinical 
practice. Because population-based health care databases collect data for quality-control and 
administrative purposes unrelated to scientific investigations, certain biases, such as nonresponse 
bias, recall bias, and bias from losses to follow-up, can be avoided.
Conclusion: Event detection using population-based health care databases is a new research 
tool in interventional cardiology that may allow large, low-cost, randomized clinical trials to 
reflect daily clinical practice, covering a broad range of patients and end points with complete 
lifelong follow-up.
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Introduction
In medicine, the randomized controlled clinical trial (RCT) is the gold standard in 
research design for assessing the level of evidence for new treatments.1 Nevertheless, 
the clinical applicability of RCT results has shortcomings. RCTs often focus on short-
term efficacy and safety in a controlled clinical environment among well-educated 
affluent patients.2 In addition, the scientific investigation per se may influence the 
subject and the results of an investigation, also called the Hawthorne effect.3  Important 
elements of study design are intensity of and methods for collection of follow-up 
data. These elements are likely to influence the completeness, validity, and number 
of events assessed, and may lead to biased estimates of the prognosis, because some 
study participants drop out over time.
In a population-based health care database, data are collected for quality-control or 
administrative purposes. This may reduce certain forms of bias, such as nonresponse 
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bias, recall bias, and bias from loss to follow-up, which may 
influence prognostic estimates.4 Also, there are considerable 
costs associated with conducting an RCT.
Based on our experience with head-to-head stent com-
parisons,5–8 we present a novel research tool in interventional 
cardiology: event detection using population-based health 
care databases. When event detection relies on population-
based databases, conduct of RCTs does not influence 
everyday clinical practice. Complete and lifelong follow-up 
is possible, and a large-scale RCT may be performed at 
relatively low cost.
Population-based databases
Event detection using population-based databases requires 
access to existing health care databases, permission to merge 
different databases at the patient level, and algorithms to 
ensure anonymity for individual patients. It is essential that 
the database cover the target population over the entire study 
period and that patient migration out of the catchment area 
is minimal.9
Clinical end points in coronary  
stent trials
Treatment with coronary stents is usually assessed using 
safety end points (all-cause death, cardiac death, and 
myocardial infarction [MI]) and efficacy end points (target-
lesion or vessel revascularization [TLR or TVR] following 
percutaneous coronary intervention [PCI] or coronary bypass 
surgery).10 It is well known that study-related follow-up 
procedures may affect the number of end points detected. 
In interventional cardiology, the Benestent study11 noted 
that TVR was found more often in patients undergoing 
systematic angiographic follow-up than in patients followed 
clinically. Thus, mandated angiographic monitoring increases 
event rates significantly, as the presence of visually assessed 
coronary artery stenosis leads to new revascularization 
 procedures. Much effort has been made to avoid study-
induced repeat revascularizations. In the Nordic Bifurcation 
studies,12 clinical and angiographic monitoring were sepa-
rated in time, with clinical follow-up preceding angiographic 
control. Other investigators have established strict rules for 
revascularization following angiographic detection of a new 
coronary artery narrowing.13
Clinical study-related monitoring by means of outpatient 
visits or telephone contacts also is likely to lead to changes 
in patient compliance, increased detection of events, and reg-
istration of events that would remain undetected in everyday 
clinical practice.
Event detection using population 
databases in the Sort Out trials
The Sort Out II–V trials5–8 used existing national registries 
covering the entire population to detect events in the study 
cohorts. Thus, participants were exposed to the same clinical 
monitoring as nonstudy patients. Data on mortality  (cardiac 
and noncardiac) were obtained from the Danish Civil 
Registration System and the National Registry of Causes of 
Death,14,15 hospital admission for myocardial infarction from 
the Danish National Registry of Patients,16 and basic descrip-
tive data, coronary angiography, repeat PCI, and coronary 
bypass surgery from the Western Denmark Heart Registry.17 
An important advantage of this study approach is the ability to 
describe baseline demographics and clinical outcomes in all 
patients treated with coronary stents during the study period, 
and not only those included in the RCT. Thus, important 
information is available regarding the general applicability, 
ie, the external validity, of study results.
In Denmark, all citizens have a personal civil registra-
tion number assigned at birth or upon immigration.14 This 
unique personal identifier allows linkage of individual-level 
information across registries and databases. The Danish Civil 
Registration System is updated daily, and maintains records 
on date of birth, death, and current residence of all Danish 
citizens. The Danish National Registry of Patients contains 
information on all admissions and outpatient visits to the 
52 Danish hospitals. For each hospital admission, the registry 
records dates of admission and discharge, surgical procedures 
performed, and up to 20 diagnoses classified according to the 
International Classification of Diseases (ICD), eighth revi-
sion, until the end of 1993, and tenth revision thereafter.16 
The Western Denmark Heart Registry contains detailed 
patient- and procedure-specific information on all coronary 
angiographies, coronary interventions and coronary bypass 
surgery performed at the three interventional and eight 
noninterventional cardiac centers in Western Denmark.17 
Information from the Western Denmark Heart Registry and 
the Danish National Registry of Patients has been validated 
in earlier studies, and the registries’ data completeness and 
validity are continuously monitored.16,18 The Sort Out trials5–8 
used the Danish Civil Registration System to assess all-cause 
mortality. The original death certificates were obtained from 
the National Registry of Causes of Death to classify deaths 
by underlying cause.
We defined new MIs as rehospitalization for MI after the 
index PCI, based on MI-related admissions and readmis-
sions I (ICD-10 codes I21–I21.9) identified from the Danish 
National Patient Registry. Information on new diagnostic 
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angiograms and new revascularizations performed with 
coronary bypass surgery or PCI was available from the 
Western Denmark Heart Registry. All possible end points 
were adjudicated by an independent end-point committee 
consisting of interventional and noninterventional cardiolo-
gists, who examined hospital files and reviewed diagnostic 
and therapeutic angiograms. The trial end points were all-
cause death, cardiac death, noncardiac death, MI, TVR, TLR, 
and stent thrombosis, using Academic Research Consortium 
definitions.10 The health care database-based event detection 
is shown schematically in Figure 1.
Randomization linked  
to a health care database
In the ongoing Swedish TASTE trial,19,20 the investigators 
have added a randomization module to their population-based 
PCI database, taking the integration of clinical databases and 
RCTs to a higher level. In TASTE, patients admitted with 
acute ST-elevation MI for primary PCI are randomized to 
thrombectomy or to conventional primary PCI. When initial 
procedural data are entered in the database and prespecified 
inclusion and exclusion criteria are fulfilled, the operator will 
have to consider randomization. This is an excellent example 
of a study design incorporating the essentials of an RCT 
in interventional cardiology. The study has a large sample 
size (.5,000 patients), a high inclusion rate, and a focused 
primary end point (1-month all-cause mortality).19 Combin-
ing event detection using population-based health care data-
bases with a randomization module may be a very efficient 
and cost-effective option when designing large scale RCTs 
with long term follow-up.
Discussion
Event detection using population-based registries in RCTs 
is a novel research tool that may be applied in a number of 
clinical settings, including coronary interventions.21 This 
approach allows large RCTs to reflect daily clinical practice, 
to cover a broad range of patients, and to facilitate complete 
lifelong follow-up at low cost.
Drug-eluting stents were accepted for extensive clinical 
use based on randomized trials involving relatively few and 
selected patients, with angiographic follow-up data serving 
as the primary end point.22–24 Years later, detection of an 
increased risk of late stent thrombosis in patients treated with 
these stents raised questions about the scientific rigor of the 
device-approval process. Subsequently, large RCTs with 
few exclusion criteria and clinical end points were recom-
mended to document acceptable safety and efficacy of new 
stents. Event detection using population-based databases 
may provide additional clinical support for this type of study. 
Danish Civil Registration System
National Registry of
Causes of Death
National Registry of
Patients
Western Denmark
Heart Registry
PCI and CABGHospital admissionsDeath
Cardiac
death
Non-cardiac
death
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Figure 1 Event detection using population-based health care databases. The Danish Civil Registration System allows linkage of individual-level information across registries.14 It 
is updated daily, and maintains records on date of birth, death, and current residence of all Danish citizens. The National Registry of Causes of Death provides information on 
causes of death.15 The National Registry of Patients contains information on all admissions and outpatient visits.16 The Western Denmark Heart Registry provides detailed patient- 
and procedure-specific information on all coronary angiographies, coronary interventions, and coronary bypass surgery procedures performed in Western Denmark.17
Abbreviations: PCI, percutaneous coronary intervention; CABg, coronary artery bypass grafting; MI, myocardial infarction; UAP, unstable angina pectoris; SAP, stable 
angina pectoris; TLR, target-lesion revascularization; ISR, in-stent restenosis; ST, stent thrombosis.
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This method may make it possible, at low cost, to use an RCT 
design to study the safety and efficacy of medical devices in 
large cohorts of unselected patients, with a lifelong follow-up 
period and a clinical research setting identical to routine 
clinical practice.
Furthermore, combining different health care databases 
may allow assessment of variables not directly related to 
the RCT for generation of hypotheses for new prospec-
tive studies.25,26 Finally, combining event detection using 
population-based health care databases and a randomization 
module within the database20 may be a very efficient and 
cost-effective option for large-scale long-term follow-up 
RCTs.
We do not know the extent to which event rates differ 
between clinical studies using population database-based 
event detection and those using conventional angiographic or 
other follow-up for event detection. It is likely that registra-
tion of death will be the same. With symptom-driven event 
detection, incidence of spontaneous MI may be slightly 
reduced and procedure-related MI further reduced due to 
fewer revascularizations. Because new revascularizations 
will be symptom-driven, it also is likely that rates of new 
revascularizations will be lower. However, the randomiza-
tion process would balance possible under- or overreporting 
in the study groups.
The generalizability, or external validity, of study findings 
is a common challenge in clinical research, since informa-
tion about nonstudy patients remains unknown or associated 
with a high degree of uncertainty. In this context, trials using 
population-based health care databases for event detection 
provide a significant advantage.25,26 Since all patients are reg-
istered in the existing databases, equally valid procedure and 
background information is available for both study patients 
and nonstudy patients.
Limitations
Databases have important limitations, which are frequently 
ignored, because researchers do not control methods of 
data collection. Therefore, a primary concern in health care 
database-based event detection is related to the quality of 
health care databases used. Here, a prerequisite is reliable 
population-based databases, which register all relevant data 
in a timely manner in a well-defined population. Additional 
requirements include the ability to identify all patients and 
link their data among different databases. Further, it is impor-
tant to review and validate the information recorded in the 
databases continuously.25
So far, our population-based health care database event 
detection has not been evaluated or approved by competent 
national health authorities. Further, we have no comparison 
of traditional event detection using clinical follow-up by 
phone call or outpatient visits and data registration by clinical 
research forms versus our proposed health care database-
based event detection. Therefore, we may suggest a random-
ized comparison of the different forms of event detection to 
describe possible event-rate differences and a comparison of 
event rates and types of events detected by traditional event 
detection versus a health care database-based event detection 
in the same study cohort.
Ethical considerations
There are specific ethical aspects to using population-based 
health care database event detection in RCTs. First, the 
randomized patient should be informed how follow-up data 
will be obtained, and that, in principle, the event detection 
will be lifelong. Second, randomized and nonrandomized 
patients should be informed that treatment and outcome 
data will be registered in national health care databases and 
used to describe general treatment results and to assess the 
external validity of ongoing RCTs.
Conclusion
Event detection using population-based health care databases 
is a new research tool in interventional cardiology that may 
allow large RCTs to reflect daily clinical practice, to cover 
a broad range of patients, and to facilitate complete lifelong 
follow-up at low cost.
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